Literature DB >> 20070937

Mumps outbreak in Jerusalem affecting mainly male adolescents.

C Stein-Zamir1, H Shoob, N Abramson, E Tallen-Gozani, I Sokolov, G Zentner.   

Abstract

From mid-September 2009 to 7 December 2009, 173 cases of mumps have been reported in the Jerusalem District. Most cases (82.1%) were male adolescents (median age 14.5 years) who are students in religious boarding schools. The majority of them (74%) are appropriately vaccinated for their age; 67% had received two doses of mumps-containing vaccine. An epidemiologic connection has been reported with visitors from New York, some of whom had recently had mumps.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20070937

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  19 in total

1.  Factors influencing preclinical in vivo evaluation of mumps vaccine strain immunogenicity.

Authors:  B Halassy; T Kurtović; M Brgles; M Lang Balija; D Forčić
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Characteristics of a large mumps outbreak: Clinical severity, complications and association with vaccination status of mumps outbreak cases.

Authors:  C Stein Zamir; H Schroeder; H Shoob; N Abramson; G Zentner
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Estimates of mumps seroprevalence may be influenced by antibody specificity and serologic method.

Authors:  Donald R Latner; Marcia McGrew; Nobia J Williams; Sun B Sowers; William J Bellini; Carole J Hickman
Journal:  Clin Vaccine Immunol       Date:  2013-12-26

4.  Assessment of mumps virus-specific antibodies by different serological assays: which test correlates best with mumps immunity?

Authors:  R Allwinn; B Zeidler; K Steinhagen; E Rohwäder; S Wicker; H F Rabenau; H W Doerr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-01       Impact factor: 3.267

5.  An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada.

Authors:  Shelley L Deeks; Gillian H Lim; Mary Anne Simpson; Louise Gagné; Jonathan Gubbay; Erik Kristjanson; Cecilia Fung; Natasha S Crowcroft
Journal:  CMAJ       Date:  2011-05-16       Impact factor: 8.262

Review 6.  Mumps: an Update on Outbreaks, Vaccine Efficacy, and Genomic Diversity.

Authors:  Eugene Lam; Jennifer B Rosen; Jane R Zucker
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

7.  Molecular epidemiological evaluation of the recent resurgence in mumps virus infections in Ireland.

Authors:  Michael J Carr; Eibhlín Moss; Allison Waters; Jonathan Dean; Li Jin; Suzie Coughlan; Jeff Connell; William W Hall; Jaythoon Hassan
Journal:  J Clin Microbiol       Date:  2010-07-21       Impact factor: 5.948

8.  Outbreak-related mumps vaccine effectiveness among a cohort of children and of young adults in Germany 2011.

Authors:  Anja Takla; Merle M Böhmer; Christina Klinc; Norbert Kurz; Alice Schaffer; Heribert Stich; Petra Stöcker; Ole Wichmann; Judith Koch
Journal:  Hum Vaccin Immunother       Date:  2013-10-07       Impact factor: 3.452

9.  Reemergence of mumps.

Authors:  Kyong Min Choi
Journal:  Korean J Pediatr       Date:  2010-05-31

10.  Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies.

Authors:  M Šantak; M Lang-Balija; J Ivancic-Jelecki; T Košutić-Gulija; S Ljubin-Sternak; D Forcic
Journal:  Epidemiol Infect       Date:  2012-09-07       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.